Brief: Basecamp Research Raises $140 Mln In Oversubscribed Series C Funding
BRIEF-Basecamp Research Raises $140 Mln In Oversubscribed Series C Funding Sept 23 (Reuters) - Basecamp Research:
BASECAMP RESEARCH: RAISES $140 MILLION IN OVERSUBSCRIBED SERIES C FUNDING LED BY S32 TO ADVANCE AI-DESIGNED THERAPEUTICS
BASECAMP RESEARCH: ADDITIONAL INVESTMENT COMES FROM SENIOR LEADERS ACROSS PHARMA, BIOTECH & GLOBAL INDUSTRY, INCLUDING ROCHE VICE-CHAIR ANDRÉ HOFFMANN
BASECAMP RESEARCH: ROUND INCLUDES PARTICIPATION FROM ANTHROPIC'S ANTHOLOGY FUND, NVIDIA, EUROPEAN TECH COLLECTIVE, NATO INNOVATION FUND & OTHERS
BASECAMP RESEARCH: CO VALUED AT $800 MILLION
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Roche Holding AG
See all newsNovartis presents weaker-than-expected relapse data for multiple sclerosis drug remibrutinib
Brief: Roche Says Sefaxersen Achieved Statistically Significant 43.1% Reduction In Proteinuria In Interim Phase III Data
Brief: Zymeworks Signs Exclusive Global Licensing Deal With Roche For Cancer Drug ZW209
Zymeworks licenses experimental lung cancer drug to Roche in up to $813 million deal
DB ups Roche to 'buy' on positive oncology survey